Categories: News

AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1

EMERYVILLE, Calif., Feb. 22, 2022 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2021, on the morning of Tuesday, March 1, 2022, prior to the opening of the financial markets.

The company will hold a conference call and webcast at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), during which, John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss Amyris’ financial results and provide an update on the company’s business. Participants may access the live webcast on Amyris’ Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing (844) 850-0551 (domestic) or (412) 902-4203 (international) and asking to join the Amyris, Inc. call.

About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company’s proprietary Lab-to-Market technology platform. This Amyris technology platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world’s top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.

Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

 

View original content:https://www.prnewswire.com/news-releases/amyris-to-host-fourth-quarter-and-full-year-2021-financial-results-conference-call-on-march-1-301486820.html

SOURCE Amyris, Inc.

Staff

Recent Posts

Amazfit Introduces Active Max: Bigger, Brighter, and Built for Maximum Performance

The newest member of the Active family blends new design, expanded storage, and longer battery…

22 minutes ago

Pulse Urgent Care Notifies Individuals of Data Security Incident

REDDING, Calif., Dec. 29, 2025 /PRNewswire/ -- Docs Medical Group, Inc. dba Pulse Urgent Care…

3 hours ago

Interactive Strength Inc. (NASDAQ:TRNR) Provides Update on Sportstech Transaction

AUSTIN, TEXAS / ACCESS Newswire / December 29, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR"…

3 hours ago

In Spite of Trump’s Marijuana Executive Order, FDA Hemp and Marijuana Botanical Guidance Will Prevail

FDA Law-Not Hemp, Marijuana Politics-Will Decide the Future of Cannabinoid Medicine.Why "Full-Spectrum CBD" Narratives Are…

3 hours ago

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…

9 hours ago

Tri-City Cardiology’s Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care

MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…

9 hours ago